Global Coordination of Antimicrobial
Resistance Research

The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, is a global collaborative organisation and platform, engaging 29 nations to curb antimicrobial resistance (AMR) with a One Health approach.

29

countries

137

projects & networks

125

M€ invested

Strategic Research & Innovation Agenda

The JPIAMR Strategic Research and Innovation Agenda on Antimicrobial Resistance (SRIA) presents an overview of recent developments and future needs for AMR research.

AMR Knowledge Hub

JPIAMR provides here access to a collection of resources on AMR research networks, research performing institutes or centres and infrastructures.

JPIAMR media library

Find here videos and communications material produced by JPIAMR to dissiminate the results and outcomes from supported projects and JPIAMR workshops.

Latest events

Event picture for webinar on social sciences and AMR

Social sciences as a cross-cutting theme in AMR research and innovation

Sep 7, 2022 10:00 - Sep 7, 2022 (CEST)

The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR. This webinar gives an overview of how different social scientific fields could deepen the understanding of the AMR issue.

Tackling the emerging threat of fungal drug resistance

Jun 23, 2022 14:00 - Jun 23, 2022 (CEST)

Invasive fungal infections pose a threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. This live webinar will discuss the emerging threat of fungal drug resistance and identify opportunities and priorities in fungal resistance research.

Developing Diagnostic tools for Drug Resistant Infections for Human and Animal Health

Jun 22, 2022 13:30 - Jun 22, 2022 (CEST)

In this workshop we will explore the main barriers to industry in developing diagnostic tools for drug-resistant infections for human and animal health and how JPIAMR and other stakeholders (industry, academia, funders, and regulatory agencies, among others) can work together to improve the translation of these developments.

Developing Novel Antimicrobial Therapeutics

Jun 21, 2022 13:00 - Jun 21, 2022 (CEST)

JPIAMR, in partnership with Innovate UK KTN, are hosting this innovation workshop to provide information about the challenges in translating academic research to commercial and not-for-profit technology solutions.

View all events

Latest news

Pills on green background

Main achievements of Therapeutics research projects and networks

May 13, 2022

A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.

Social sciences as a cross-cutting theme in JPIAMR research priorities

May 5, 2022

The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR.

Consultation: antiparasitic and antiviral resistance

Apr 29, 2022

The JPIAMR has launched a round of consultation on antiparasitic and antiviral resistance. The information will be used for outlining research and innovation priorities in the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance and informing the scope and direction of the candidate One Health AMR partnership. 

Review from the JPIAMR SRIA fungal resistance group published in Nature Reviews Microbiology

Apr 5, 2022

The review “Tackling the emerging threat of antifungal resistance to human health” has been published in the April edition of Nature Reviews Microbiology. The review was written by the expert group on antifungals that led the broadening on the JPIAMR Strategic Research and Innovation Agenda in 2021.

View all news